These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11435021)

  • 1. Successful management of an ovarian enlargement resembling ovarian hyperstimulation in a premenopausal breast cancer patient receiving tamoxifen with cotreatment of GnRH-agonist.
    Turan C; Unal O; Dansuk R; Guzelmeric K; Cengizoglu B; Esim E
    Eur J Obstet Gynecol Reprod Biol; 2001 Jul; 97(1):105-7. PubMed ID: 11435021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful co-treatment with LHRH-agonist for ovarian over-stimulation and cystic formation in premenopausal tamoxifen exposure.
    Cohen I; Tepper R; Figer A; Flex D; Shapira J; Beyth Y
    Breast Cancer Res Treat; 1999 May; 55(2):119-25. PubMed ID: 10481939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cyst torsion and extreme ovarian stimulation in a premenopausal patient treated with tamoxifen for ductal carcinoma in situ of the breast.
    Taran A; Eggemann H; Costa SD; Smith B; Bischoff J
    Am J Obstet Gynecol; 2006 Oct; 195(4):e5-6. PubMed ID: 17000228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer.
    Shushan A; Peretz T; Uziely B; Lewin A; Mor-Yosef S
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):141-4. PubMed ID: 8571997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer.
    Shulman A; Cohen I; Altaras MM; Maymon R; Ben-Nun I; Tepper R; Beyth Y
    Hum Reprod; 1994 Aug; 9(8):1427-9. PubMed ID: 7989499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic approach to ovarian cysts in tamoxifen-treated women with breast cancer.
    Shushan A; Peretz T; Mor-Yosef S
    Int J Gynaecol Obstet; 1996 Mar; 52(3):249-53. PubMed ID: 8775677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients.
    Cohen I; Figer A; Tepper R; Shapira J; Altaras MM; Yigael D; Beyth Y
    Gynecol Oncol; 1999 Feb; 72(2):202-7. PubMed ID: 10021302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cysts in tamoxifen-treated women with breast cancer.
    Inal MM; Incebiyik A; Sanci M; Yildirim Y; Polat M; Pilanci B; Nayki C; Camuzcuoğlu H
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):104-6. PubMed ID: 15866095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cysts during tamoxifen use may affect the prognostic markers of premenopausal breast cancer.
    Han W; Kim H; Ku SY; Kim SH; Choi YM; Kim JG; Moon SY
    Gynecol Endocrinol; 2013 Jan; 29(1):16-9. PubMed ID: 22812679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth.
    Cohen I; Rosen DJ; Altaras M; Beyth Y; Shapira J; Yigael D
    Br J Cancer; 1994 Mar; 69(3):620-1. PubMed ID: 8123501
    [No Abstract]   [Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone agonists for the management of ovarian cysts in menopause breast cancer patients on tamoxifen treatment.
    Kourounis G; Zervoudis S; Michail G; Fotopoulos A
    Breast J; 2005; 11(5):365-6. PubMed ID: 16174165
    [No Abstract]   [Full Text] [Related]  

  • 12. Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cancer.
    Tan SH; Wolff AC
    Clin Breast Cancer; 2007 Feb; 7(6):455-64. PubMed ID: 17386122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen and ovarian cysts: a prospective study.
    Seoud M; El-saghir N; Salem Z; Shamseddine A; Awwad J; Medawar W; Khalil A
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 100(1):77-80. PubMed ID: 11728662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of ovarian cysts in breast cancer cases on tamoxifen.
    Mofrad MH; Shandiz FH; Roodsare FV; Moghiman T
    Asian Pac J Cancer Prev; 2010; 11(1):161-4. PubMed ID: 20593950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cyst formation in patients using tamoxifen for breast cancer.
    Metindir J; Aslan S; Bilir G
    Jpn J Clin Oncol; 2005 Oct; 35(10):607-11. PubMed ID: 16254040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.
    Klijn JG; Blamey RW; Boccardo F; Tominaga T; Duchateau L; Sylvester R;
    J Clin Oncol; 2001 Jan; 19(2):343-53. PubMed ID: 11208825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsion of a functional ovarian cyst in a premenopausal patient receiving tamoxifen.
    Nasu K; Miyazaki T; Kiyonaga Y; Kawasaki F; Miyakawa I
    Gynecol Obstet Invest; 1999; 48(3):200-2. PubMed ID: 10545747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A follicular cyst during tamoxifen therapy in a premenopausal breast cancer woman.
    Terada S; Uchide K; Suzuki N; Akasofu K
    Gynecol Obstet Invest; 1993; 35(1):62-4. PubMed ID: 8449438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.